363
Views
7
CrossRef citations to date
0
Altmetric
Article

Neoadjuvant chemotherapy for muscle invasive bladder cancer: a nationwide investigation on survival

ORCID Icon, , , , , & show all
Pages 206-212 | Received 20 Feb 2019, Accepted 23 May 2019, Published online: 07 Jun 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

I. Koskinen, P. J Boström, P. Taimen, A. Salminen, M. Tervahartiala, J. Sairanen, A. Erickson & T. Mirtti. (2021) Prediction of neo-adjuvant chemotherapy response in bladder cancer: the impact of clinical parameters and routine biomarkers. Scandinavian Journal of Urology 55:6, pages 448-454.
Read now

Articles from other publishers (6)

Giulio Scola, Anca Chis Ster, Daniel Bean, Nilesh Pareek, Richard Emsley & Sabine Landau. (2023) Implementation of the trial emulation approach in medical research: a scoping review. BMC Medical Research Methodology 23:1.
Crossref
Erik Wiberg, Andrés Vega, Victoria Eriksson, Viqar Banday, Johan Svensson, Elisabeth Eriksson, Staffan Jahnson & Amir Sherif. (2023) A Validation Study of cT-Categories in the Swedish National Urinary Bladder Cancer Register—Norrland University Hospital. Journal of Personalized Medicine 13:7, pages 1163.
Crossref
Christina Tanem Møller, Nathalie C. Støer, Augun Blindheim, Viktor Berge, Gunnar Tafjord, Sophie D. Fosså & Bettina Kulle Andreassen. (2022) Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study. BMC Cancer 22:1.
Crossref
Dong Hyuk Kang, Kang Su Cho, Young Joon Moon, Doo Yong Chung, Hae Do Jung & Joo Yong Lee. (2022) Effect of neoadjuvant chemotherapy on overall survival of patients with T2-4aN0M0 bladder cancer: A systematic review and meta-analysis according to EAU COVID-19 recommendation. PLOS ONE 17:4, pages e0267410.
Crossref
Shuai Liu, Yu Yao, Fengju Guan, Lijiang Sun & Guiming Zhang. (2022) Neoadjuvant Chemotherapy for Different Stages of Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis. Disease Markers 2022, pages 1-11.
Crossref
Artur Lemiński, Krystian Kaczmarek, Tomasz Byrski & Marcin Słojewski. (2021) Neoadjuvant chemotherapy with dose dense MVAC is associated with improved survival after radical cystectomy compared to other cytotoxic regimens: A tertiary center experience. PLOS ONE 16:11, pages e0259526.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.